BMI View: Bulgaria's expanding private healthcare market will provide significant revenue-earning
opportunities for multinational pharmaceutical firms and medical device manufacturers. The poor state of
the public healthcare system and the liberalisation of the privat ..."
BMI View: The vote of no confidence against Bulgaria's government, despite being unsuccessful, has
highlighted the dissatisfaction of a large proportion of the population with proposed healthcare reforms. A
number of recent controversies have lowered the public's opin ..."
BMI View: Bulgaria's healthcare sector is in need of reform to improve its efficiency; however, it is likely
to see spending cuts as the government must enforce strong cost-saving measures to reduce the budget
deficit. Such controls to healthcare spending will produce ..."
BMI View: Pharmaceutical companies in Bulgaria will face increased pricing pressures from the National
Health Insurance Fund (NHIF) as it unveils more cost-containment measures to rein in pharmaceutical
expenditure. The NHIF will increasingly leverage its purchasing p ..."
BMI View: Strong pharmaceutical sales growth in 2015 will be moderated over the medium term by cost
containment measures. Healthcare payers in Central and Eastern Europe will become increasingly
assertive in using their purchasing power to demand discounts from drugma ..."
BMI View: Pharmaceutical manufacturers will face increased pricing pressures from the National Health
Insurance Fund (NHIF) as we expect a wave of cost-containment measures to be adopted. The NHIF will
leverage its purchasing power to reduce its runaway pharmaceutical ..."
BMI View: In 2015, we expect the fallout from the banking and NHIF funding crises to impact
pharmaceutical and healthcare spending, but given the passage of reforms to healthcare financing, we hold
a more positive view for the long term development of the pharmaceutical & h ..."
BMI View: Large order increases from within the hospital sector and robust consumer demand will spur
pharmaceutical sales growth in 2014 and 2015. However, external slowdown will begin to impact the
Bulgarian market from 2015 onwards. Bulgaria's healthcare system will ..."
SeeNews Research on Demand Human health activities, Bulgaria - Company Names, Contacts, Key Managers and Financial Figures
SeeNews Research on Demand Human health activities, Bulgaria report provides you the most up-to-date and easy-to-use information of 8226 companies, operat ..."
BMI View: The Ministry of Health's plan to increase MAH fees, coupled with price cuts for generic drugs
and freezes on OTC medicine prices indicate that the Bulgarian pharmaceutical market will not see
meaningful growth in 2014. However, we expect a pickup in demand f ..."